Management of nephropathy in patients with type 2 diabetes

Chinese Medical Journal

Volumn 115, Issue 1, 2002, Pages 129-135

  Julian Critchley, A J H ^a   Zhao, Hai Lu ^a   Tomlinson, Brian ^a   Leung, Wilson ^a   Thomas, Gneil ^a   Chan, Juliana C N ^a   Cockram, Clive S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Albuminuria; Hypertension; Nephropathy; Renin angiotensin system; Type 2 diabetes

Indexed keywords

ALBUMIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUINDOSTATIN; GLICLAZIDE; GLIPIZIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LIPID; LOSARTAN; METFORMIN; MEVINOLIN; POTASSIUM; PRAVASTATIN; SIMVASTATIN; SULFONYLUREA DERIVATIVE; TELMISARTAN; THIAZIDE DIURETIC AGENT; TOLBUTAMIDE; UNINDEXED DRUG; VALSARTAN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD PRESSURE REGULATION; CHINESE; CLINICAL RESEARCH; DIABETIC NEPHROPATHY; DIET THERAPY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DYSLIPIDEMIA; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HONG KONG; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOGLYCEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; LACTIC ACIDOSIS; MEDICAL LITERATURE; MEDLINE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT CARE; PATIENT MONITORING; PREDICTION; PROSPECTIVE STUDY; PROTEIN RESTRICTION; RISK FACTOR; SCREENING TEST; SMOKING CESSATION;

ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION;

EID: 0036158936     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Renal disease and hypertension in non-insulin-dependent diabetes mellitus
2. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
3. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
4. Diabetes in the Chinese population and its implication for health care
5. Nephropathy in patients with type 2 diabetes mellitus
6. Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy
7. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients
8. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature
9. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: Application in diabetic nephropathy
10. American Diabetes Association: Clinical practice recommendations 2000
11. Hyperhomocysteinemia in type 2 diabetes: Relationship to macroangiopathy, nephropathy, and insulin resistance
12. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
13. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial
14. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
15. Complications in IDDM are caused by elevated blood glucose level: The Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up
16. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
17. Hypertension and diabetes: New therapeutic options
18. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes
19. Effects of antihypertensive therapy on progression of diabetic nephropathy
20. Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy
21. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy
22. Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials
23. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients
24. Preserving renal function in adults with hypertension and diabetes: A consensus approach
25. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy
26. Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?
27. Effects of hypertension and dyslipidaemia on the decline in renal function
28. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
29. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis
30. Blood presure control, proteinuria, and the progression of renal disease: The modification of diet in renal disease study